A Southern California cannabis company is praising a federal court decision that clarifies some of the 2018 Farm Bill’s scope regarding legal cannabinoids.
Today, San Diego-based Medical Marijuana, Inc. (MMI) subsidiary Kannaway applauded the Ninth U.S. Circuit Court of Appeals for ruling that Delta-8 THC is legal under the 2018 Farm Bill.
In celebration, Kannaway is expanding its hemp-derived product line with new liquid and gummy Delta-8 THC products.
Delta-8 is a cannabinoid that occurs naturally in small amounts on the cannabis plant, but people can also synthesize it from cannabidiol (CBD).
The cannabinoid has caused some controversy in recent years as local, state, and federal governments were unsure how to address its legality.
“The 2018 Farm Bill made it clear that hemp with a THC level of less than 0.3% is federally legal, says” MMI CEO Blake Schroeder. “As the creator of the world’s first cannabidiol-based product, we are proud of our accomplishments and the clarity that the Farm Bill provides. We applaud the Ninth Circuit for its decision which correctly applied the Farm Bill language to Delta-8.”
Schroeder says that, as leaders of innovation in the cannabis industry, MMI celebrates free access to legal cannabinoids and is excited about its new Delta-8 products.
According to Kannaway, the Ninth Circuit’s ruling is good for the cannabis industry as consumer interest in Delta-8 THC has grown in recent years.
The surge in interest may come from modern research pointing to possible health benefits from Delta-8 THC use.
With a growing number of consumers expanding their cannabinoid intake range, Kannway says analysts predict that Delta-8 THC products have the potential to be the fastest-growing segment of the hemp-derived product market.
Brightfield Group social listening data shows that online conversations regarding Delta-8 THC increased 163 percent from December 2020 to April 2021.
